rs555607708
This variant is located in the CHEK2 gene.
▶GWAS Catalog Trait Associations (2)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
GWAS Catalog Trait Associations (2)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
prostate carcinoma
clonal hematopoiesis
▶ClinVar annotation
Astrocytoma; Bone osteosarcoma; Breast and colorectal cancer, susceptibility to; Breast and/or ovarian cancer; Breast cancer, susceptibility to; Breast carcinoma; Breast neoplasm; Breast-ovarian cancer, familial, susceptibility to, 1 (BROVCA1); CHEK2-related cancer predisposition; CHEK2-related disorder; Carcinoma of pancreas; Colorectal cancer; Familial cancer of breast; Familial prostate cancer; Hereditary breast ovarian cancer syndrome; Hereditary cancer-predisposing syndrome; Inherited breast cancer and ovarian cancer; Leiomyosarcoma; Li-Fraumeni syndrome (LFS); Li-Fraumeni syndrome 1 (LFS); Li-Fraumeni syndrome 2 (TPDS4); Malignant tumor of breast; Malignant tumor of prostate; NICE approved PARP inhibitor treatment; Ovarian neoplasm; Predisposition to cancer; TUMOR PREDISPOSITION SYNDROME 4, BREAST/PROSTATE/COLORECTAL
View on ClinVar →About CHEK2
In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
View all CHEK2 variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…